Among which, ESR2 was shown to be involved in the estrogen and prolactin signaling pathways and may take a significant role in the effect of germacrone, curdione, and furanodiene in the treatment of breast cancers and should be studied in animal models. Here, PRL is linked to breast carcinoma.